Skip to content
10-Q

Quarterly Report

NORTHWEST BIOTHERAPEUTICS INC NWBO

0001104659-25-112676

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 1.54B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.22M sh
Capex Q3 2025 · Sep 30, 2025 $599K
Capex Q3 2025 · Sep 30, 2024 $936K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$30M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$36.84M
Long Term Debt Q3 2025 · Sep 30, 2025 $72.2M
Long Term Debt Q3 2025 · Dec 31, 2024 $62.68M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.56M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.18M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$108.65M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$100.39M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$94.49M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$80.12M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$76.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$65.77M
Current Liabilities Q3 2025 · Sep 30, 2025 $87.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $68.27M
Total Liabilities Q3 2025 · Sep 30, 2025 $125.86M
Total Liabilities Q3 2025 · Dec 31, 2024 $105.71M
Current Assets Q3 2025 · Sep 30, 2025 $7.2M
Current Assets Q3 2025 · Dec 31, 2024 $4.06M
Total Assets Q3 2025 · Sep 30, 2025 $30.61M
Total Assets Q3 2025 · Dec 31, 2024 $26.73M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.05
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.05
Sga Expense Q3 2025 · Sep 30, 2025 $7.07M
Sga Expense Q3 2025 · Sep 30, 2025 $23.89M
Sga Expense Q3 2025 · Sep 30, 2024 $7.03M
Sga Expense Q3 2025 · Sep 30, 2024 $24.8M
Rd Expense Q3 2025 · Sep 30, 2025 $7.45M
Rd Expense Q3 2025 · Sep 30, 2025 $23.23M
Rd Expense Q3 2025 · Sep 30, 2024 $8.13M
Rd Expense Q3 2025 · Sep 30, 2024 $24.37M
Net Income Q3 2025 · Sep 30, 2025 −$26.83M
Net Income Q3 2025 · Sep 30, 2025 −$61.55M
Net Income Q3 2025 · Sep 30, 2024 −$19.37M
Net Income Q3 2025 · Sep 30, 2024 −$55.56M
Operating Income Q3 2025 · Sep 30, 2025 −$14.32M
Operating Income Q3 2025 · Sep 30, 2025 −$46.41M
Operating Income Q3 2025 · Sep 30, 2024 −$14.8M
Operating Income Q3 2025 · Sep 30, 2024 −$48.01M
Revenue Q3 2025 · Sep 30, 2025 $200K
Revenue Q3 2025 · Sep 30, 2025 $706K
Revenue Q3 2025 · Sep 30, 2024 $357K
Revenue Q3 2025 · Sep 30, 2024 $1.15M